Second-generation antipsychotics and the risk of chronic kidney disease: a population-based case-control study
Objectives To examine the association between use of second-generation antipsychotics (SGA) and the risk of chronic kidney disease (CKD).Design Population-based case-control study.Setting Routinely collected laboratory, prescription and diagnostic information on all inhabitants with creatinine measu...
Saved in:
| Main Authors: | Daniel Pilsgaard Henriksen, Per Damkier, Mikkel Højlund, Lars Christian Lund, Jonas Leander Emming Herping, Maija Bruun Haastrup |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-08-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/8/e038247.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of ileus risk in selected second-generation antipsychotics based on FAERS database
by: Yaqian Tan, et al.
Published: (2025-05-01) -
Hyperprolactinemia during application of second-generation antipsychotics: the principles of prevention, diagnosis and correction
by: L. N. Gorobets, et al.
Published: (2018-07-01) -
Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
by: Montemagni C, et al.
Published: (2016-04-01) -
Treatment of Acute Psychosis with Second-Generation Antipsychotics in a Patient with Left Temporal Lobe Lesion
by: Richard Shehane, et al.
Published: (2018-01-01) -
Prevalence of organ failure and mortality among patients in the emergency department: a population-based cohort study
by: Annmarie Touborg Lassen, et al.
Published: (2019-10-01)